Can Treatment With Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2016
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Embolism and thrombosis; Fetal growth retardation
- Focus Therapeutic Use
- 15 Jul 2016 Status changed from recruiting to completed.
- 18 May 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Aug 2016.
- 08 Jun 2015 Planned End Date changed from 1 Nov 2013 to 1 Sep 2016 as reported by ClinicalTrials.gov record.